TABLE 5.

Susceptibility, prevalence of aminoglycoside-modifying enzyme genotypes, and clonal diversity of 45 isolates of A. baumannii-calcoaceticus complex from burn intensive care unit

GenotypeSubstrate(s)aPFGE type (no. of isolates)
200620072008
ant(2")-IaGEN, TOB3 (2)2 (3)
aac(3)-IaGEN5 (4)5 (1)
aac(6′)-IhTOB, AMK5 (5)
aac(3)-IIaGEN, TOB14 (2)
aac(3)-Ia + aph(3′)-IaGEN4 (1)
aac(3)-Ia + ant(2")-IaGEN, TOB9 (1)
aac(6′)-Ih + aph(3′)-IaTOB, AMK7 (1), 13 (2)
aph(3′)-Ia + aph(3′)-VI1 (1)
aph(3′)-Ia + ant(2")-IaGEN, TOB1 (7), 11 (1)1 (10)
aph(3′)-VI + ant(2")-IaGEN, TOB, AMK1 (1), 11 (1)
aac(3)-Ia + aph(3′)-Ia + aph(3′)-VIGEN7 (1)
aac(3)-Ia + aph(3′)-Ia + ant(2")-IaGEN, TOB1 (1)
  • a GEN, gentamicin; TOB, tobramycin; AMK, amikacin.